From March 10, 2023 to April 10, 2023, the company has repurchased 2,210,500 shares, representing 1.73% for INR 3,149.96 million. With this, the company has completed the repurchase of 2,210,500 shares, representing 1.73% for INR 3,149.96 million under the buyback announced on March 10, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,395 INR | +0.58% | +0.74% | +14.94% |
05-03 | INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh | RE |
05-02 | Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.94% | 3.59B | |
+21.63% | 44.12B | |
+22.99% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.61B | |
+60.18% | 13.34B | |
-8.35% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- AJANTPHARM Stock
- News Ajanta Pharma Limited
- Tranche Update on Ajanta Pharma Limited's Equity Buyback Plan announced on March 10, 2023.